Document is current
Any future updates will be listed below
-
Authors
Bastin, Alireza
Netticadan, Thomas
Abbasi, Fatemeh
Rahimi, Naseeb
Mahmoodi, Marzieh
Alizadeh, Mehdi
Movahed, Ali
Momeni-Moghaddam, Mohammad Amin
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20111119008129n13 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
Effects of resveratrol on inflammatory cytokines in COVID-19 patients: a randomized, double-blinded, placebo-controlled clinical trial
https://doi.org/10.1007/s11010-025-05290-3
-
Funding
Funding for this research was provided by:
Bushehr University of Medical Sciences (IR.BPUMS.REC.1400.159)
Bushehr University of Medical Sciences (IR.BPUMS.REC.1400.159)
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 8 April 2025
First Online: 30 April 2025
Declarations
:
: The authors declare no competing interests.
